Antonio C Wolff

Professor

1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2019

In reply

(on behalf of the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Guideline Expert Panel), Apr 2019, In : Archives of Pathology and Laboratory Medicine. 143, 4, p. 413-414 2 p.

Research output: Contribution to journalLetter

Open Access
2018

Preferred clinician communication about stopping cancer screening among older US adults: Results from a national survey

Schoenborn, N. L., Janssen, E., Boyd, C. M., Bridges, J., Wolff, A. C. & Pollack, C. E., Aug 1 2018, In : JAMA oncology. 4, 8, p. 1126-1128 3 p.

Research output: Contribution to journalLetter

Reply to C. Murray et al and v. Martin et al

Wolff, A. C., Hammond, M. E. H., Allison, K. H., Harvey, B. E., McShane, L. M. & Dowsett, M., Dec 10 2018, In : Journal of Clinical Oncology. 36, 35, p. 3524 1 p.

Research output: Contribution to journalLetter

2017

Reply to L. Del Mastro and A. Prat

Denduluri, N., Somerfield, M. R., Eisen, A., Holloway, J. N., Hurria, A., King, T. A., Lyman, G. H., Partridge, A. H., Telli, M. L., Trudeau, M. E. & Wolff, A. C., Apr 1 2017, In : Journal of Clinical Oncology. 35, 10, p. 1139 1 p.

Research output: Contribution to journalLetter

2015

Reply to E.A. Rakha et al

Wolff, A. C., Elizabeth, M., Hammond, H., Hicks, D. G., Allison, K. H., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., Hanna, W., Jenkins, R. B., Mangu, P. B., Paik, S., Perez, E. A., Press, M. F., Spears, P. A., Vance, G. H., Viale, G., Dowsett, M., McShane, L. M. & Hayes, D. F., Mar 20 2015, In : Journal of Clinical Oncology. 33, 11, p. 1302-1303 2 p.

Research output: Contribution to journalLetter

2014

Reply to R. Bhargava et al and K. Lambein et al

Wolff, A. C., Elizabeth H Hammond, M., Hicks, D. G., Dowsett, M., Hayes, D. F. & McShane, L. M., Jun 10 2014, In : Journal of Clinical Oncology. 32, 17, p. 1857-1859 3 p.

Research output: Contribution to journalLetter

2012

Re: Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria

Wolff, A. C., Hammond, M. E. & Hayes, D. F., Jun 20 2012, In : Journal of the National Cancer Institute. 104, 12, p. 957-958 2 p.

Research output: Contribution to journalLetter

With maturity comes confidence: EBCTCG tamoxifen update

Chia, S. K. & Wolff, A. C., Jan 1 2011, In : The Lancet. 378, 9793, p. 747-749 3 p.

Research output: Contribution to journalLetter

2009

African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women

Balmanoukian, A., Zhang, Z., Jeter, S., Slater, S., Armstrong, D. K., Emens, L. A., Fetting, J. H., Wolff, A. C., Davidson, N. E., Jacobs, L., Lange, J., Tsangaris, T. N., Zellars, R., Gabrielson, E. & Stearns, V., Aug 1 2009, In : Journal of Clinical Oncology. 27, 22, p. e35-e37

Research output: Contribution to journalLetter

Reply to G. Sauter et al

Hammond, E. H., Wolff, A. C., Hayes, D. F. & Schwartz, J. N., Oct 20 2009, In : Journal of Clinical Oncology. 27, 30, p. e153-e154

Research output: Contribution to journalLetter

2008

Are short-term or long-term recurrence rates more important in breast cancer screening?

Goodman, S. N., Marchionni, L. & Wolff, A. C., Sep 2 2008, In : Annals of internal medicine. 149, 5, p. 357-358 2 p.

Research output: Contribution to journalLetter

2007

In reply [3]

Wolff, A. C., Hammond, M. E. H., Schwartz, J. N. & Hayes, D. F., Sep 1 2007, In : Journal of Clinical Oncology. 25, 25, p. 4021-4023 3 p.

Research output: Contribution to journalLetter

In reply [3]

Wolff, A. C., Hammond, M. E. H., Schwartz, J. N. & Hayes, D. F., Sep 1 2007, In : Archives of Pathology and Laboratory Medicine. 131, 9, p. 1331-1333 3 p.

Research output: Contribution to journalLetter

The authors respond [2]

Cianfrocca, M. E., Lurie, R. H. & Wolff, A. C., Apr 1 2007, In : ONCOLOGY. 21, 4, p. 524-525 2 p.

Research output: Contribution to journalLetter

2006

Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support [3]

Wolff, A. C., Jones, R. J., Davidson, N. E., Jeter, S. C. & Stearns, V., May 20 2006, In : Journal of Clinical Oncology. 24, 15, p. 2392-2394 3 p.

Research output: Contribution to journalLetter